Monopar Therapeutics Inc. - stock earnings
MNPR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -2.0 million USD | ? USD |
| 2023Q2 | -2.2 million USD | ? USD |
| 2023Q1 | -2.3 million USD | ? USD |
| 2022Q4 | -2.9 million USD | ? USD |
| 2022Q3 | -2.4 million USD | ? USD |
| 2022Q2 | -2.8 million USD | ? USD |
| 2022Q1 | -2.5 million USD | ? USD |
| 2021Q4 | -2.7 million USD | ? USD |
| 2021Q3 | -2.5 million USD | ? USD |
| 2021Q2 | -2.1 million USD | ? USD |
| 2021Q1 | -1.9 million USD | ? USD |
| 2020Q4 | -2.1 million USD | ? USD |
| 2020Q3 | -1.6 million USD | ? USD |
| 2020Q2 | -1.4 million USD | ? USD |
| 2020Q1 | -1.1 million USD | ? USD |
| 2019Q4 | -1.2 million USD | ? USD |
| 2019Q3 | -736080 USD | ? USD |
| 2019Q2 | -905700 USD | ? USD |
| 2019Q1 | -1.4 million USD | ? USD |
| 2018Q4 | -890461 USD | ? USD |
| 2018Q3 | -640184 USD | ? USD |
| 2018Q2 | -820939 USD | ? USD |
| 2018Q1 | -876347 USD | ? USD |
| 2017Q4 | -713583 USD | ? USD |
| 2017Q3 | -14.9 million USD | ? USD |
| 2017Q2 | -591438 USD | ? USD |
| 2017Q1 | -372915 USD | ? USD |
MNPR Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -9.5 million USD | ? USD |
| 2022 | -10.5 million USD | ? USD |
| 2021 | -9.1 million USD | ? USD |
| 2020 | -6.2 million USD | 122400 USD |
| 2019 | -4.1 million USD | ? USD |
| 2018 | -3.2 million USD | ? USD |
| 2017 | -16.6 million USD | ? USD |
| 2016 | -1.2 million USD | ? USD |
| 2015 | -687311 USD | ? USD |
MNPR
Price: $0.66
52 week price:
Earnings Per Share: -0.72 USD
P/E Ratio: -0.51
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 123422
Market Capitalization: 8.9 million